Shah points to research published September 2 in which older mice given semaglutide lived longer, with effects he says went beyond blood sugar control.
Recap by typeshit. Post by @darshanshahmd on Instagram.
EMY covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which cancers are in the full story.
The review weighs weight and metabolic benefits in people with IBD against early lab hints of anti-inflammatory effects, and looks at what observational studies show so far.
The obesity doctor takes on why some people see weaker results on GLP-1 medications. Short clip with few details given.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
Loading…